Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Accured Expenses: 2013-2025

Historic Change in Accured Expenses for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to -$2.8 million.

  • Fortress Biotech's Change in Accured Expenses rose 43.33% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.9 million, marking a year-over-year increase of 31.49%. This contributed to the annual value of -$6.4 million for FY2024, which is 73.79% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Change in Accured Expenses is -$2.8 million, which was up 66.38% from -$8.4 million recorded in Q2 2025.
  • Fortress Biotech's Change in Accured Expenses' 5-year high stood at $28.1 million during Q3 2021, with a 5-year trough of -$17.5 million in Q3 2023.
  • In the last 3 years, Fortress Biotech's Change in Accured Expenses had a median value of -$4.3 million in 2023 and averaged -$3.8 million.
  • In the last 5 years, Fortress Biotech's Change in Accured Expenses soared by 2,251.09% in 2021 and then tumbled by 8,292.96% in 2023.
  • Over the past 5 years, Fortress Biotech's Change in Accured Expenses (Quarterly) stood at $9.4 million in 2021, then tumbled by 57.89% to $3.9 million in 2022, then tumbled by 286.95% to -$7.4 million in 2023, then spiked by 109.89% to $728,000 in 2024, then skyrocketed by 43.33% to -$2.8 million in 2025.
  • Its Change in Accured Expenses stands at -$2.8 million for Q3 2025, versus -$8.4 million for Q2 2025 and $590,000 for Q1 2025.